1. Shareholder Sues Tyme Technologies Alleging Misrepresentations During Merger with Syros Pharmaceuticals

    Shareholder Sues Tyme Technologies Alleging Misrepresentations During Merger with Syros Pharmaceuticals

    On Tuesday, Richard Lawrence filed a complaint in the District of Delaware against Tyme Technologies, Inc. and its corporate directors alleging securities violations in connection with an attempted merger with Syros Pharmaceuticals, Inc. According to the complaint, Tyme is a Delaware corporation traded on the Nasdaq and a biotechnology company focused on developing cancer metabolism-based therapies...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Topics Mentioned

  3. Authors